142 related articles for article (PubMed ID: 8746921)
21. Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans.
Greenwald MK; Schuh KJ; Hopper JA; Schuster CR; Johanson CE
Psychopharmacology (Berl); 2002 Apr; 160(4):344-52. PubMed ID: 11919661
[TBL] [Abstract][Full Text] [Related]
22. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
[TBL] [Abstract][Full Text] [Related]
23. Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
Janiri L; Mannelli P; Persico AM; Serretti A; Tempesta E
Drug Alcohol Depend; 1994 Oct; 36(2):139-45. PubMed ID: 7851281
[TBL] [Abstract][Full Text] [Related]
24. Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting.
Amato P
Clin Drug Investig; 2010; 30 Suppl 1():33-9. PubMed ID: 20450244
[TBL] [Abstract][Full Text] [Related]
25. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
26. Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial.
Rosenthal RN; Lofwall MR; Kim S; Chen M; Beebe KL; Vocci FJ;
JAMA; 2016 Jul; 316(3):282-90. PubMed ID: 27434441
[TBL] [Abstract][Full Text] [Related]
27. Effects of high-dose intravenous buprenorphine in experienced opioid abusers.
Umbricht A; Huestis MA; Cone EJ; Preston KL
J Clin Psychopharmacol; 2004 Oct; 24(5):479-87. PubMed ID: 15349002
[TBL] [Abstract][Full Text] [Related]
28. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study.
Threlkeld M; Parran TV; Adelman CA; Grey SF; Yu J
Am J Addict; 2006; 15(2):186-91. PubMed ID: 16595358
[TBL] [Abstract][Full Text] [Related]
29. Characterizing opioid withdrawal during double-blind buprenorphine detoxification.
Dunn KE; Saulsgiver KA; Miller ME; Nuzzo PA; Sigmon SC
Drug Alcohol Depend; 2015 Jun; 151():47-55. PubMed ID: 25823907
[TBL] [Abstract][Full Text] [Related]
30. Naltrexone and buprenorphine combination in the treatment of opioid dependence.
Gerra G; Fantoma A; Zaimovic A
J Psychopharmacol; 2006 Nov; 20(6):806-14. PubMed ID: 16401652
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
[TBL] [Abstract][Full Text] [Related]
32. A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification.
Amass L; Bickel WK; Higgins ST; Hughes JR
J Addict Dis; 1994; 13(3):33-45. PubMed ID: 7734458
[TBL] [Abstract][Full Text] [Related]
33. A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence.
Petry NM; Bickel WK; Badger GJ
Clin Pharmacol Ther; 1999 Sep; 66(3):306-14. PubMed ID: 10511067
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.
Webster L; Hjelmström P; Sumner M; Gunderson EW
J Addict Dis; 2016; 35(4):325-338. PubMed ID: 27267785
[TBL] [Abstract][Full Text] [Related]
35. Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification.
Sobel BF; Sigmon SC; Walsh SL; Johnson RE; Liebson IA; Nuwayser ES; Kerrigan JH; Bigelow GE
Drug Alcohol Depend; 2004 Jan; 73(1):11-22. PubMed ID: 14687955
[TBL] [Abstract][Full Text] [Related]
36. Examining the limits of the buprenorphine interdosing interval: daily, every-third-day and every-fifth-day dosing regimens.
Petry NM; Bickel WK; Badger GJ
Addiction; 2001 Jun; 96(6):823-34. PubMed ID: 11399214
[TBL] [Abstract][Full Text] [Related]
37. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids.
Cheskin LJ; Fudala PJ; Johnson RE
Drug Alcohol Depend; 1994 Oct; 36(2):115-21. PubMed ID: 7851278
[TBL] [Abstract][Full Text] [Related]
38. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse.
Schottenfeld RS; Pakes JR; Oliveto A; Ziedonis D; Kosten TR
Arch Gen Psychiatry; 1997 Aug; 54(8):713-20. PubMed ID: 9283506
[TBL] [Abstract][Full Text] [Related]
39. Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.
Marsch LA; Bickel WK; Badger GJ; Jacobs EA
Drug Alcohol Depend; 2005 Feb; 77(2):195-204. PubMed ID: 15664721
[TBL] [Abstract][Full Text] [Related]
40. Comparison of buprenorphine and methadone in the treatment of opioid dependence.
Strain EC; Stitzer ML; Liebson IA; Bigelow GE
Am J Psychiatry; 1994 Jul; 151(7):1025-30. PubMed ID: 8010359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
